BARIUM SULFATE vs IOPAMIDOL

Compare BARIUM SULFATE (E-Z-Paque) and IOPAMIDOL (iopamidol) — clinical data, side effects, and patient experiences.

BARIUM SULFATE

E-Z-Paque · Diagnostic Agent

How it works

Diagnostic Agent agent

Approved for

1 INDICATIONS AND USAGE Liquid E-Z-PAQUE is indicated for use in single contrast radiographic examinations of the esophagus

stomach

and small bowel to visualize the gastrointestinal (GI) tract in adult and pediatric patients ( 1 )

OralTablet

IOPAMIDOL

iopamidol · Diagnostic Agent

How it works

Diagnostic Agent agent

Approved for

INDICATIONS AND USAGE Iopamidol Injection is indicated for intrathecal administration in adult neuroradiology including myelography (lumbar

thoracic

cervical

total columnar)

IntrathecalTablet

Quick Comparison

BARIUM SULFATEIOPAMIDOL

Drug Class

Diagnostic Agent

Route

Oral

Intrathecal

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

BARIUM SULFATE

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Headache

1-10%

Dizziness

1-10%

Drug Not Working

1-10%

Joint Pain

1-10%

Shortness of Breath

1-10%

IOPAMIDOL

Shortness of Breath

1-10%

Itching

1-10%

Nausea

1-10%

Vomiting

1-10%

Fever

0.1-1%

Cough

0.1-1%

FDA Warnings

BARIUM SULFATE

5 WARNINGS AND PRECAUTIONS Hypersensitivity reactions: Emergency equipment and trained personnel should be immediately available ( 5
3 ) Aspiration pneumonitis: Patients with history of food aspiration or with swallowing disorders are at increased risk ( 5
1 Hypersensitivity Reactions Barium sulfate preparations contain a number of excipients, including natural and artificial flavors and may induce serious hypersensitivity reactions
A history of bronchial asthma, atopy or a previous reaction to a contrast agent may increase the risk for hypersensitivity reactions

IOPAMIDOL

WARNINGS The need for myelographic examination should be carefully evaluated
If frankly bloody cerebrospinal fluid is observed, the possible benefits of a myelographic examination should be considered in terms of risk to the patient
Inadvertent intracranial entry of a large or concentrated bolus of the contrast medium, which increases the risk of neurotoxicity, can be prevented by careful patient management

Clinical Trial Data

No head-to-head clinical studies found for BARIUM SULFATE vs IOPAMIDOL.

BARIUM SULFATE vs IOPAMIDOL: What You Should Know

Key Differences

Both BARIUM SULFATE and IOPAMIDOL belong to the Diagnostic Agent class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. BARIUM SULFATE is administered via Oral, whereas IOPAMIDOL uses Intrathecal. Route of administration can affect onset of action and patient adherence.

Safety Considerations

BARIUM SULFATE carries 4 FDA warnings. IOPAMIDOL carries 3 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

GADOBUTROL vs IOPAMIDOL→AIR 90% CARBON DIOXIDE 10% vs IOPAMIDOL→CARBON DIOXIDE vs IOPAMIDOL→IODIXANOL vs IOPAMIDOL→IOHEXOL vs IOPAMIDOL→GADODIAMIDE vs IOPAMIDOL→

Loading comparison data...

BARIUM SULFATE vs IOPAMIDOL

Compare BARIUM SULFATE (E-Z-Paque) and IOPAMIDOL (iopamidol) — clinical data, side effects, and patient experiences.

BARIUM SULFATE

E-Z-Paque · Diagnostic Agent

How it works

Diagnostic Agent agent

Approved for

1 INDICATIONS AND USAGE Liquid E-Z-PAQUE is indicated for use in single contrast radiographic examinations of the esophagus

stomach

and small bowel to visualize the gastrointestinal (GI) tract in adult and pediatric patients ( 1 )

OralTablet

IOPAMIDOL

iopamidol · Diagnostic Agent

How it works

Diagnostic Agent agent

Approved for

INDICATIONS AND USAGE Iopamidol Injection is indicated for intrathecal administration in adult neuroradiology including myelography (lumbar

thoracic

cervical

total columnar)

IntrathecalTablet

Quick Comparison

BARIUM SULFATEIOPAMIDOL

Drug Class

Diagnostic Agent

Route

Oral

Intrathecal

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

BARIUM SULFATE

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Headache

1-10%

Dizziness

1-10%

Drug Not Working

1-10%

Joint Pain

1-10%

Shortness of Breath

1-10%

IOPAMIDOL

Shortness of Breath

1-10%

Itching

1-10%

Nausea

1-10%

Vomiting

1-10%

Fever

0.1-1%

Cough

0.1-1%

FDA Warnings

BARIUM SULFATE

5 WARNINGS AND PRECAUTIONS Hypersensitivity reactions: Emergency equipment and trained personnel should be immediately available ( 5
3 ) Aspiration pneumonitis: Patients with history of food aspiration or with swallowing disorders are at increased risk ( 5
1 Hypersensitivity Reactions Barium sulfate preparations contain a number of excipients, including natural and artificial flavors and may induce serious hypersensitivity reactions
A history of bronchial asthma, atopy or a previous reaction to a contrast agent may increase the risk for hypersensitivity reactions

IOPAMIDOL

WARNINGS The need for myelographic examination should be carefully evaluated
If frankly bloody cerebrospinal fluid is observed, the possible benefits of a myelographic examination should be considered in terms of risk to the patient
Inadvertent intracranial entry of a large or concentrated bolus of the contrast medium, which increases the risk of neurotoxicity, can be prevented by careful patient management

Clinical Trial Data

No head-to-head clinical studies found for BARIUM SULFATE vs IOPAMIDOL.

BARIUM SULFATE vs IOPAMIDOL: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.